| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.096 | 0.06 |